SynBiotic SE (FRA:SBX)
Germany
· Delayed Price · Currency is EUR 1.634
-0.108 (-6.20%)
At close: Dec 4, 2025
SynBiotic SE Revenue
In the year 2023, SynBiotic SE had annual revenue of 3.86M EUR, down -52.71%. SynBiotic SE had revenue of 3.55M in the quarter ending June 30, 2024.
Revenue
3.86M
Revenue Growth
-52.71%
P/S Ratio
2.92
Revenue / Employee
70.21K
Employees
55
Market Cap
11.28M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Rheinmetall AG | 11.00B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Deutsche Bank Aktiengesellschaft | 29.86B |
SynBiotic SE News
- 6 weeks ago - EQS-News: SYNBIOTIC welcomes Green Party’s proposal for the Industrial Hemp Liberalization Act and calls for objectivity in the medical cannabis debate - Wallstreet:Online
- 6 weeks ago - Temporary headwinds from regulatory uncertainty; chg. est. - Wallstreet:Online
- 2 months ago - EQS-News: Positive Outlook: Cannabis Legalization Review and Trump’s Endorsement Send Encouraging Signals - Wallstreet:Online
- 4 months ago - EQS-News: Across the pond: SYNBIOTIC attracts international investors with established intercontinental networks - Wallstreet:Online
- 4 months ago - SynBiotic Eyes Triple Revenue by 2027 in Cannabis & Hemp Markets - Wallstreet:Online
- 8 months ago - EQS-DD: SYNBIOTIC SE: HempConsult GmbH, Lending (free of charge) of 50,000 shares as part of a securities lending programme. - Wallstreet:Online